Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Clinical trial NCT03096340 · TERMINATED
Trial details
- NCT number
- NCT03096340
- Sponsor
- Intezyne Technologies, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-23
- Primary completion
- 2018-08-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.